ORM-5029

News alerts, weekly reports and conference planners

Company:

Orum Therap

Drug class:

HER2-targeted antibody-drug conjugate, HER3-targeted antibody-drug conjugate, GSPT1 degrader

Related drugs:

‹

›

GSPT1 deletion	Breast Cancer	GSPT1 deletion	Breast Cancer	ORM-5029 Sensitive: D – Preclinical ORM-5029 Sensitive : D	ORM-5029 Sensitive: D – Preclinical ORM-5029 Sensitive : D
HER-2 expression	Breast Cancer	HER-2 expression	Breast Cancer	ORM-5029 Sensitive: D – Preclinical ORM-5029 Sensitive : D	ORM-5029 Sensitive: D – Preclinical ORM-5029 Sensitive : D

Associations
(2)